Results 251 to 260 of about 51,600 (308)

Case Report: Dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma-a proteome analysis. [PDF]

Front Allergy
Blauwblomme M, Gevaert P, Van Nevel S, Riemann S, Vandewalle E, Holtappels G, De Ruyck N, Derycke L, Eeckels AS, Vanhee S, Lambrecht BN, Brusselle G, Van Zele T.   +12 more
europepmc   +1 more source

Effects of benralizumab in patients with severe eosinophilic asthma (SEA): A plain language summary of the ANANKE study. [PDF]

Immunotherapy
Canonica GW, Consani L, Malerba L, Pelaia G, Vultaggio A, ANANKE investigators.   +5 more
europepmc   +1 more source

Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication. [PDF]

Immunotherapy
Jackson DJ, Pelaia G, Emmanuel B, Tran TN, Cohen D, Shih VH, Shavit A, Arbetter D, Katial R, Rabe APJ, Garcia Gil E, Pardal M, Nuevo J, Watt M, Boarino S, Kayaniyil S, Loureiro CC, Padilla-Galo A.   +17 more
europepmc   +1 more source

Bullous Wells’ syndrome successfully treated with omalizumab

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Giulia Ciccarese, William Andrew Rosato, Francesco Drago, Alexandre Raphael Meduri, Francesca Ambrogio, Aurora De Marco, Gerardo Cazzato, Caterina Foti   +7 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Eosinophilic Asthma

The Journal of Allergy and Clinical Immunology: In Practice, 2020
Asthma endotypes are constantly evolving. Currently, there are no universally accepted criteria to define endotypes. The TH2-high endotype can have either allergic or nonallergic underpinnings and is typically characterized by some degree of eosinophilic airway inflammation.
Ryan K, Nelson, Andrew, Bush, Jeffrey, Stokes, Parameswaran, Nair, Praveen, Akuthota   +4 more
openaire   +2 more sources

Eosinophil diversity in asthma

Biochemical Pharmacology, 2020
Eosinophils are a type of granulated innate immune cells that have long been implicated in a specific type of asthma, referred to as eosinophilic asthma. Several immunotherapeutics that target and deplete eosinophils or limit their numbers are currently widely used and provide improved disease outcome in severe eosinophilic asthma.
Van Hulst, Glenn, Batugedara, Hashini Maneesha, Jorssen, Joseph, Louis, Renaud, Bureau, Fabrice, Desmet, Christophe   +5 more
openaire   +3 more sources

Eosinophils and asthma

Current Allergy and Asthma Reports, 2007
Recruitment and activation of eosinophils into the airways of asthma patients is suggested to be a contributing causative agent in the histopathologies and lung dysfunction that are characteristic of asthma. Recent studies in mouse models of asthma and in human patients implicate eosinophils in immune regulation and remodeling in the lung in addition ...
Elizabeth A, Jacobsen, Sergei I, Ochkur, Nancy A, Lee, James J, Lee   +3 more
openaire   +2 more sources

Eosinophilic Bronchitis without Asthma

International Archives of Allergy and Immunology, 2008
<i>Background:</i> Eosinophilic bronchitis without asthma causes chronic coughs without the physiologic features of asthma. The aim of this study was to review the clinical features, pathogenesis, diagnosis, treatment and prognosis of this condition.
GÖNLÜGÜR, UĞUR, GÖNLÜGÜR, UĞUR
openaire   +3 more sources